New hope for men with advanced penile cancer after chemotherapy fails
NCT ID NCT07497919
Summary
This study is testing a new two-drug combination for men with advanced penile cancer that has spread and who cannot tolerate or have not responded to standard chemotherapy. The trial will see if the drugs becotatug vedotin and pucotenlimab can help control the cancer. It aims to enroll about 20 participants to measure how well the treatment works and how safe it is.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PENILE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.